Join to View Full Profile
160 E 34th StNew York, NY 10016
Phone+1 212-731-5165
Fax+1 212-263-8460
Dr. Chachoua is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Monash University Faculty of MedicineClass of 1979
Certifications & Licensure
NY State Medical License 1989 - 2027
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Top Doctors: New York Metro Area Castle Connolly, 2007-2014
- New York Magazine: Top Doctors Castle Connolly, 2007-2009, 2012-2014
- Join now to see all
Clinical Trials
- Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma Start of enrollment: 1998 Sep 01
- R115777 in Treating Patients With Relapsed Small Cell Lung Cancer Start of enrollment: 1999 Sep 01
- Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy Start of enrollment: 1997 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Automating the Referral of Bone Metastases Patients With and Without the Use of Large Language Models.Karl L Sangwon, Xu Han, Anton Becker, Yuchong Zhang, Richard Ni
Neurosurgery. 2025-08-15 - Implementation of culturally relevant sexual and gender minority/sexual orientation and gender identity training at an NCI-Designated Cancer Center.Jason D Domogauer, Alexandr Trifonov, Kevin Moore, Megan Haseltine, Rachel Nelson
Journal of the National Cancer Institute. Monographs. 2025-07-01 - 1 citationsEarly experience with PEF in the setting of recalcitrant stage IV lung cancer.William H Moore, Mikhail Silk, Priya Bhattacharji, Bradley B Pua, Joseph Mammarappallil
Lung Cancer. 2025-06-01
Journal Articles
- Radiotherapy Induces Responses of Lung Cancer to CTLA-4 BlockadeAbraham Chachoua, Silvia C Formenti, Benjamin Cooper, Kent Friedman, Sandra Demaria, Nature
Press Mentions
Franco Muggia, a Drug Developer and Former Director of NYU Langone’s Perlmutter Cancer Center, Died Unexpectedly on Sept. 8September 17th, 2021- NYU Langone Brings Top Talent to Advance Cancer Care in BrooklynMarch 11th, 2021
- Around Brooklyn: BP Adams Joins Anti-Diabetes EffortNovember 17th, 2020
- Join now to see all
Grant Support
- Su101 In Patients W/ Psa+ Prostate Cancer(101 008)National Center For Research Resources1999–2002
- Cisplatin Analog In Malignant Pleural MesotheliomaNational Center For Research Resources2000
- IL-1 Combined With High Dose Cisplatinum For Metastatic MelanomaNational Center For Research Resources1995–1996
- Evaluations Of Cytokine And Chemotherapy CombinationsNational Cancer Institute1992–1994
- Recombinant Human Interleukin-1 In Refractory Carcinoma PatientsNational Center For Research Resources1993
- Gmcsf And Murine Monoclonal Antibody R24 For Metastatic MelanomaNational Center For Research Resources1992–1993
- Recombinant Human Interleukin 1 In Refractory Carcinoma PatientsNational Center For Research Resources1991–1992
- Phase II Trial Of Bropirimine In Aids/KsNational Center For Research Resources1988
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
